|
|
Sponsored Links
|
Study shows RAD001 froze kidney cancer for a yearFriday, May 16, 2008 WASHINGTON (Reuters) - Nearly two-thirds of kidney cancer patients taking Novartis AG's RAD001 had progression of their disease delayed by a year, a significantly better result than in those taking placebo, investigators said.

Read Complete Story
|
Sponsored Links
Tools
Bookmark/Discuss
|
|
|